📑Fournitures de reactifs et consommables de laboratoires - 464 lots.
Procurement process summary
This process is to purchase Fournitures de reactifs et consommables de laboratoires - 464 lots.
This contract was awarded by 🇫🇷 CHU de Nantes for an amount of EUR 13,116,444 to 1 supplier. It was published on 2014-04-16 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇫🇷 CHU de Nantes Buying unitnot reported Publication date2014-04-16 Contest statusnot reported DescriptionFournitures de reactifs et consommables de laboratoires -- repartie en 464 lots.Awards
This award was granted to Qiagen by CHU de Nantes for an amount of EUR 13,116,444. The procurement process was conducted through open for the category of goods. This is award number 13.
This contract has multiple awards. This is award number 13. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇫🇷 Qiagen | EUR 13,116,444 | 13 |
Market context and opportunities
The execution of this contract allows the entity CHU de Nantes to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberFR_ocds-70d2nz-6d64a30f-2806-4103-a044-ca34e8683c6c-award-13Publication date2014-04-16Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
